APA (7th ed.) Citation

L, J., J, P., N, L., J, C., & Y, Z. (2026). LncRNA-PRLB drives ovarian cancer progression and chemoresistance by stabilizing GPX4 mRNA through the FUS-mediated suppression of ferroptosis. Frontiers in medicine, 13, 1759058. https://doi.org/10.3389/fmed.2026.1759058

Chicago Style (17th ed.) Citation

L, Jiang, Pi J, Li N, Cao J, and Zhao Y. "LncRNA-PRLB Drives Ovarian Cancer Progression and Chemoresistance by Stabilizing GPX4 MRNA Through the FUS-mediated Suppression of Ferroptosis." Frontiers in Medicine 13 (2026): 1759058. https://doi.org/10.3389/fmed.2026.1759058.

MLA (9th ed.) Citation

L, Jiang, et al. "LncRNA-PRLB Drives Ovarian Cancer Progression and Chemoresistance by Stabilizing GPX4 MRNA Through the FUS-mediated Suppression of Ferroptosis." Frontiers in Medicine, vol. 13, 2026, p. 1759058, https://doi.org/10.3389/fmed.2026.1759058.